2024-02-01 12:36:15 ET
Summary
- Century Therapeutics is a biotech focused on developing engineered natural killer cells for cancer and rheumatologic conditions.
- Their first clinical product, CNTY-101, showed promising early data with a patient experiencing tumor shrinkage and a complete clinical response.
- However, Century Therapeutics has a limited cash position and needs to prove the efficacy of their therapies before being considered a confident investment.
Topline Summary
Read the full article on Seeking Alpha
For further details see:
Century Therapeutics: More Attention Doesn't Mean You Should Buy Into INK Cell Therapy